Search Results

You are looking at 31 - 40 of 1,080 items for :

  • "community" x
  • Refine by Access: All x
Clear All
Full access

HSR20-093: Psychosocial Support in Older Patients With Metastatic Breast Cancer (MBC) Treated at Community Centers

Bianca Lewis, Caitlin R. Meeker, Elizabeth Handorf, Kelly Filchner, Rino Seedor, Jennifer S. Winn, Lori J. Goldstein, and Efrat Dotan

analysis, we sought to describe the psychosocial profile of older community patients with MBC, and investigate the correlation between psychosocial factors and presence of other GA abnormalities. Methods: This study included hands-on experience

Full access

Trials and Tribulations for Adolescents and Young Adults with Cancer: Measuring the Impact of a Community-Based Program

Howland E. Crosswell, Kaitlin N. Bomar, Nicole Vickery, Kristina Stoeppler-Biege, Terra D. Spann, and Robert D. Siegel

approximately 80% of the nearly 70,000 AYA patients diagnosed annually in the United States are seen and/or cared for in the community, understanding and implementing AYA care delivery in nonacademic settings is important. Recent updates to the NCCN Clinical

Full access

YIA22-005: A Randomized Trial of Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting

Shivan J. Mehta, Sanjay Palat, Catherine Reitz, Evelyn Okorie, Caitlin McDonald, Pamela A. Shaw, Karen Glanz, and David A Asch

Background : Effective prevention and screening exists for colorectal cancer (CRC) but is underutilized, particularly in community health settings. Colonoscopy and fecal immunochemical testing (FIT) are both considered top-tier tests according

Full access

CGE23-073: Tissue and Liquid Biopsy Utilization in Advanced NSCLC in a Large Community US Practice

Alison Roos, Lucio Gordan, Michael Diaz, Anjan Patel, Matthew Fink, David Wenk, John Jiang, Janice Tam, Pratheesh Sathyan, and Phil Febbo

tissue biopsy-based biomarker testing and reflex testing dynamics to understand the current NSCLC biomarker testing scenario in a large US community practice. Methods: Patients with advanced NSCLC (n=250) who received care in a large US community

Full access

HSR24-135: Community Oncologists’ Perceptions on the Evolving Role of Surrogate Endpoints in Oncologic Clinical Trials

Brooke Leon, Robert N. Bone, Yolaine Jeune-Smith, and Bruce Feinberg

efficient clinical drug development. This survey-based study aimed to evaluate community oncologists’ perceptions on the evolving role of surrogate endpoints in clinical trials and how the use of these endpoints has impacted the oncology care continuum

Full access

QIM24-176: Technology’s Impact on Implementing the NCCN Distress Thermometer in a Community-Based Oncology Clinic

Grant Andres, Kelly Huey, Lorraine Lopez, Christine Bates, Maria Acosta, Cyndie Harrelson, and Donald Brooks

cancer treatment. Screening for distress in a community-based oncology clinic represents an opportunity to mitigate barriers to successful treatment. Recently, the distress screening tool was approved by the CMS Enhancing Oncology Model as a means of

Full access

CGE22-100: Community Oncologists’ Current and Future Patterns of Germline Testing for Patients With Early-Stage Breast Cancer

Dewilka Simons, Yolaine Jeune-Smith, Bruce Feinberg, Stephanie Fortier, and Ajeet Gajra

surveyed community hematologists/oncologists (cH/O) on their perceptions of the OlympiA trial data and the potential impact on their BRCA 1/2 testing habits in patients with early-stage BC. Methods : Between June and October 2021, practicing U.S. cH/O were

Full access

Risk of Febrile Neutropenia Associated With Select Myelosuppressive Chemotherapy Regimens in a Large Community-Based Oncology Practice

Yanli Li, Leila Family, Su-Jau Yang, Zandra Klippel, John H. Page, and Chun Chao

strengths. Data were used from a large community-based population of patients with cancer; therefore, the findings may better reflect FN risks in the real-world setting. The comprehensive clinical databases at KPSC allowed for detailed characterizations of

Full access

HSR24-163: Comparative Assessment of Social Determinants of Health in Community and Academic Hospitals for Patients Diagnosed With Hepatocellular Carcinoma

Elham Nasrollahi, Adalberto Guzman, and Anas Atrash

This study investigates the influence of social determinants of health (SDOH) on patients diagnosed with hepatocellular carcinoma (HCC) in two distinct healthcare settings: a community hospital and an academic hospital. We examined the impact of

Full access

EPR24-120: A Data-Driven Approach to Increase Lung Cancer Screening Rate in the Catchment Area of an NCI-Designated Cancer Center via Community Outreach and Engagement

Ming Lee, Rebecca E. Kaiser, Christopher D. Armstrong, David B. Dukenik, Deborah Soong, Nancy S. Elliott, Raymond R. Balise, Erin N. Kobetz, and Justin Taylor

Florida by targeting census tracts with high demand (ie, identified with both high smoking rates and high lung cancer incidences) and low utilization of lung cancer screening services for patient recruitment via community outreach and engagement. Methods